Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
Tissue Transplantation01:24

Tissue Transplantation

352
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
352
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between abuse, neglect, and at-risk family interactions with adolescent psychiatric disorders.

Child abuse & neglect·2026
Same author

Influence of at-risk family interactions on the course of psychiatric care in adolescence.

European child & adolescent psychiatry·2024
Same author

Observation of WZγ Production in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2024
Same author

Search for Dark Photons in Rare Z Boson Decays with the ATLAS Detector.

Physical review letters·2024
Same author

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

Bone marrow transplantation·2023
Same author

Observation of Single-Top-Quark Production in Association with a Photon Using the ATLAS Detector.

Physical review letters·2023

Related Experiment Video

Updated: Jun 18, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K

Current challenges in conditioning regimens for MDS transplantation.

A B Notarantonio1, M Robin2, M D'Aveni1

  • 1Hematology Department, University Hospital of Nancy, France; CNRS 7365, IMoPA, University of Lorraine, F-54000, France.

Blood Reviews
|August 1, 2024
PubMed
Summary

Allogeneic stem cell transplant is the only curative option for higher-risk myelodysplastic syndromes (MDS). Optimizing conditioning regimens to balance efficacy and toxicity remains crucial for better patient outcomes.

Keywords:
Allogeneic stem cell transplantationConditioning intensityMyelodysplastic syndromes

More Related Videos

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.4K

Related Experiment Videos

Last Updated: Jun 18, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.4K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Myelodysplastic syndrome (MDS) is a clonal disorder with heterogeneous clinical presentations.
  • Higher-risk MDS patients face poor prognoses due to high progression rates to acute myeloid leukemia.
  • Allogeneic hematopoietic stem cell transplantation (HSCT) offers durable disease control via graft-versus-MDS effects.

Purpose of the Study:

  • To review and evaluate studies on conditioning regimens for HSCT in higher-risk MDS.
  • To assess strategies for intensifying conditioning to target malignant clones.
  • To determine the optimal conditioning regimen balancing efficacy and toxicity.

Main Methods:

  • Systematic review of retrospective and prospective studies.
  • Analysis of conditioning regimen intensity and drug combinations.
  • Evaluation of toxicity profiles and treatment outcomes.

Main Results:

  • Intensifying conditioning regimens is debated due to toxicity concerns in older MDS patients.
  • New drugs have been explored to improve clone control without escalating toxicity.
  • Evidence from existing studies has limitations in defining an ideal regimen.

Conclusions:

  • The optimal conditioning regimen for higher-risk MDS undergoing HSCT requires further delineation.
  • Balancing the need for potent anti-leukemic effects with acceptable toxicity is paramount.
  • Future research should focus on developing safer and more effective conditioning strategies.